CHI3L1 and metabolic dysfunction-associated steatohepatitis: There is a preliminary report to suggest that when compared with established biomarker scoring systems, Chi3L1 gene expression may be used to distinguish between isolated simple steatosis vs. NASH by whole genome RNA sequencing (RNA-seq) [24].